s6y
Company name or ticker
Search
Nurix Therapeutics, Inc.
4
Hansen Gwenn: Statement of changes in beneficial ownership of securities
Filed
Tuesday, September 1, 2026
Period
Sep 1, 2026
Accession number
0001817160-26-000019
Documents
FORM 4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header